Corbus Pharmaceuticals Holdings (CRBP) Long-Term Investments (2022)
Corbus Pharmaceuticals Holdings (CRBP) recorded quarterly Long-Term Investments of $16.8 million in Q4 2022.
Corbus Pharmaceuticals Holdings (CRBP) Long-Term Investments (2022) Analysis & Trends
Corbus Pharmaceuticals Holdings' Long-Term Investments history runs 1 years deep, the most recent figure standing at $16.8 million for Q4 2022.
- In Q4 2022, Long-Term Investments changed N/A year-over-year to $16.8 million; the TTM figure through Dec 2022 stood at $16.8 million (changed N/A YoY), while the FY2022 annual figure was $16.8 million, changed N/A from the prior year.
- Long-Term Investments was $16.8 million for Q4 2022 at Corbus Pharmaceuticals Holdings.
- In the past five years, Long-Term Investments ranged from a high of $16.8 million in Q4 2022 to a low of $16.8 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | 5.17 Mn |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 5.75 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Corbus Pharmaceuticals Holdings | 136.49 Mn | 108.68 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 16.75 Mn |